Josh Mandel-Brehm
Direktor/Vorstandsmitglied bei PROMIS NEUROSCIENCES, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Josh Mandel-Brehm
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Direktor/Vorstandsmitglied | 01.09.2021 | - |
| Independent Dir/Board Member | 01.09.2021 | - | |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | 01.05.2017 | - |
| Vorstandsvorsitzender | 01.05.2017 | - | |
| Präsident | 01.05.2017 | - | |
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Direktor/Vorstandsmitglied | 01.09.2019 | - |
| Gründer | 01.09.2019 | - |
Karriereverlauf von Josh Mandel-Brehm
Ausbildung von Josh Mandel-Brehm
| University of Michigan | Masters Business Admin |
| Washington University in St. Louis | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Niederlande | 2 |
| Kanada | 2 |
Operativ
| Director/Board Member | 3 |
| Chief Executive Officer | 1 |
| President | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PROMIS NEUROSCIENCES, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Health Technology |
- Börse
- Insiders
- Josh Mandel-Brehm
- Erfahrung
